Kotra Industries Berhad Past Earnings Performance
Past criteria checks 2/6
Kotra Industries Berhad has been growing earnings at an average annual rate of 21.2%, while the Pharmaceuticals industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 8.8% per year. Kotra Industries Berhad's return on equity is 16.2%, and it has net margins of 19.7%.
Key information
21.2%
Earnings growth rate
20.5%
EPS growth rate
Pharmaceuticals Industry Growth | 7.7% |
Revenue growth rate | 8.8% |
Return on equity | 16.2% |
Net Margin | 19.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Kotra Industries Berhad (KLSE:KOTRA) Has Announced A Dividend Of MYR0.13
Aug 21Kotra Industries Berhad (KLSE:KOTRA) Is Paying Out A Larger Dividend Than Last Year
Feb 27Kotra Industries Berhad (KLSE:KOTRA) Is Increasing Its Dividend To MYR0.16
Oct 10Estimating The Fair Value Of Kotra Industries Berhad (KLSE:KOTRA)
Sep 16Kotra Industries Berhad (KLSE:KOTRA) Is Increasing Its Dividend To RM0.095
Feb 27Is Kotra Industries Berhad (KLSE:KOTRA) A Smart Choice For Dividend Investors?
May 05Does Kotra Industries Berhad (KLSE:KOTRA) Have A Healthy Balance Sheet?
Mar 24Be Sure To Check Out Kotra Industries Berhad (KLSE:KOTRA) Before It Goes Ex-Dividend
Mar 03Should You Rely On Kotra Industries Berhad's (KLSE:KOTRA) Earnings Growth?
Feb 21Shareholders Of Kotra Industries Berhad (KLSE:KOTRA) Must Be Happy With Their 191% Total Return
Feb 08How Does Kotra Industries Berhad (KLSE:KOTRA) Stand Up To These Simple Dividend Safety Checks?
Jan 26Declining Stock and Solid Fundamentals: Is The Market Wrong About Kotra Industries Berhad (KLSE:KOTRA)?
Jan 13Do Kotra Industries Berhad's (KLSE:KOTRA) Earnings Warrant Your Attention?
Dec 31Is Kotra Industries Berhad (KLSE:KOTRA) A Risky Investment?
Dec 18Is Kotra Industries Berhad's (KLSE:KOTRA) Shareholder Ownership Skewed Towards Insiders?
Dec 05Kotra Industries Berhad (KLSE:KOTRA) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Nov 22Is There More To The Story Than Kotra Industries Berhad's (KLSE:KOTRA) Earnings Growth?
Nov 20Revenue & Expenses Breakdown
How Kotra Industries Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 227 | 45 | 82 | 0 |
31 Mar 24 | 223 | 45 | 88 | 0 |
31 Dec 23 | 226 | 56 | 88 | 0 |
30 Sep 23 | 231 | 61 | 88 | 0 |
30 Jun 23 | 242 | 65 | 88 | 0 |
31 Mar 23 | 235 | 68 | 72 | 0 |
31 Dec 22 | 231 | 68 | 72 | 0 |
30 Sep 22 | 222 | 65 | 72 | 0 |
30 Jun 22 | 208 | 62 | 72 | 0 |
31 Mar 22 | 203 | 58 | 65 | 0 |
31 Dec 21 | 191 | 48 | 65 | 0 |
30 Sep 21 | 176 | 37 | 65 | 0 |
30 Jun 21 | 160 | 24 | 65 | 0 |
31 Mar 21 | 153 | 20 | 75 | 0 |
31 Dec 20 | 156 | 21 | 75 | 0 |
30 Sep 20 | 167 | 27 | 75 | 0 |
30 Jun 20 | 172 | 30 | 75 | 0 |
31 Mar 20 | 175 | 28 | 73 | 0 |
31 Dec 19 | 169 | 26 | 73 | 0 |
30 Sep 19 | 165 | 22 | 73 | 0 |
30 Jun 19 | 173 | 22 | 73 | 0 |
31 Mar 19 | 177 | 21 | 76 | 0 |
31 Dec 18 | 181 | 20 | 76 | 0 |
30 Sep 18 | 182 | 19 | 76 | 0 |
30 Jun 18 | 179 | 16 | 76 | 0 |
31 Mar 18 | 177 | 12 | 76 | 0 |
31 Dec 17 | 177 | 13 | 76 | 0 |
30 Sep 17 | 176 | 15 | 76 | 0 |
30 Jun 17 | 167 | 12 | 76 | 0 |
31 Mar 17 | 165 | 13 | 71 | 0 |
31 Dec 16 | 162 | 9 | 71 | 0 |
30 Sep 16 | 156 | 4 | 71 | 0 |
30 Jun 16 | 160 | 8 | 71 | 0 |
31 Mar 16 | 158 | 6 | 74 | 0 |
31 Dec 15 | 151 | 6 | 74 | 0 |
30 Sep 15 | 151 | 7 | 74 | 0 |
30 Jun 15 | 145 | 1 | 74 | 0 |
31 Mar 15 | 150 | 4 | 66 | 0 |
31 Dec 14 | 158 | 9 | 66 | 0 |
30 Sep 14 | 154 | 6 | 66 | 0 |
30 Jun 14 | 147 | 6 | 66 | 0 |
31 Mar 14 | 146 | 8 | 58 | 0 |
31 Dec 13 | 141 | 6 | 58 | 0 |
Quality Earnings: KOTRA has high quality earnings.
Growing Profit Margin: KOTRA's current net profit margins (19.7%) are lower than last year (26.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KOTRA's earnings have grown significantly by 21.2% per year over the past 5 years.
Accelerating Growth: KOTRA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: KOTRA had negative earnings growth (-31.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-13.3%).
Return on Equity
High ROE: KOTRA's Return on Equity (16.2%) is considered low.